Table 5

Cost-effectiveness analysis

ControlTelemedicineDifference
Mean (SD)95% CIMean (SD)95% CIMean (SD)95% CI
Cost (€)180.4 (17.01)(151.3 to 218.0)168.4 (19.65)(135.6 to 212.8)−11.99 (25.98)(−62.33 to 40.99)
SAHS-related cost (€)150.9 (13.14)(128.1 to 180.1)114.5 (12.08)(94.13 to 141.5)−36.35 (17.87)(−36.15 to −1.35)
Effectiveness
 QALYs0.0120 (0.0169)(−0.0211 to 0.0451)0.0108 (0.0182)(−0.0250 to 0.0467)−0.0012 (0.0248)(−0.0500 to 0.0474)
 Epworth5.079 (0.5323)(4.034 to 6.124)3.932 (0.5381)(2.869 to 4.992)−1.147 (0.7552)(−2.643 to 0.3317)
 CPAP use (h)4.179 (0.2752)(3.633 to 4.717)4.416 (0.2583)(3.911 to 4.922)0.2377 (0.377)(−0.5009 to 0.9699)
  • *Mean and SD for time variables. For other variables, number of cases and % of the sample that used this resource.

  • CPAP, continuous positive airway pressure; QALYs, quality-adjusted life years; SAHS, sleep apnoea-hypopnoea syndrome.